Squarepoint Ops LLC Pyxis Oncology, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.03 - $6.59 $138,766 - $450,479
68,358 New
68,358 $291,000
Q1 2023

May 15, 2023
BUY
$1.38 - $6.0 $52,364 - $227,670
37,945 New
37,945 $152,000
Q1 2022

May 16, 2022
SELL
$4.04 - $11.43 $126,565 - $358,079
-31,328 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$8.39 - $13.64 $262,841 - $427,313
31,328 New
31,328 $344,000

Others Institutions Holding PYXS

# of Institutions
101
Shares Held
28.2M
Call Options Held
539K
Put Options Held
54.1K
View Full List

About Pyxis Oncology, Inc.

PYXS Quotes by TradingView
  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email